Free Trial

OrthoPediatrics (KIDS) Stock Forecast & Price Target

OrthoPediatrics logo
$26.34 -0.13 (-0.49%)
(As of 11/22/2024 ET)

OrthoPediatrics - Analysts' Recommendations and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Sell
0
Hold
1
Buy
2

Based on 3 Wall Street analysts who have issued ratings for OrthoPediatrics in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 3 analysts, 1 has given a hold rating, and 2 have given a buy rating for KIDS.

Consensus Price Target

$40.00
51.86% Upside
According to the 3 analysts' twelve-month price targets for OrthoPediatrics, the average price target is $40.00. The highest price target for KIDS is $50.00, while the lowest price target for KIDS is $28.00. The average price target represents a forecasted upside of 51.86% from the current price of $26.34.
Get the Latest News and Ratings for KIDS and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for OrthoPediatrics and its competitors.

Sign Up

KIDS Analyst Ratings Over Time

TypeCurrent Forecast
11/25/23 to 11/24/24
1 Month Ago
10/26/23 to 10/25/24
3 Months Ago
8/27/23 to 8/26/24
1 Year Ago
11/25/22 to 11/25/23
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
2 Buy rating(s)
2 Buy rating(s)
3 Buy rating(s)
5 Buy rating(s)
Hold
1 Hold rating(s)
1 Hold rating(s)
1 Hold rating(s)
0 Hold rating(s)
Sell
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
Consensus Price Target$40.00$40.00$43.50$46.80
Forecasted Upside51.86% Upside55.70% Upside36.58% Upside48.67% Upside
Consensus Rating
Moderate Buy
Moderate Buy
Moderate Buy
Buy
This Bull Market Indicator called NVDA at $116 (Ad)

Every now and again we find an investment idea so incredible we can’t help but share. And today is one of those rare days… Except, today we won't be giving you insight on any one particular stock… But rather, insight on a revolutionary new stock picking indicator… In fact, within the last year, this indicator has become famous for a multitude of reasons… But one of the biggest was because of the buy signal it issued on October 18th, 2022. In fact, on that very day, it said to buy NVDA at $116.37… Anyone who did would be sitting on a tremendously large return today… But even if you missed the original buy signal from October, this incredible indicator issued 11 other buy signals while Nvidia made its epic run…

All you have to do is follow this link here

KIDS Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

KIDS Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

OrthoPediatrics Stock vs. The Competition

TypeOrthoPediatricsMedical CompaniesS&P 500
Consensus Rating Score
2.67
2.80
2.50
Consensus RatingModerate BuyModerate BuyModerate Buy
Predicted Upside51.86% Upside27,073.49% Upside7.66% Upside
News Sentiment Rating
Neutral News

See Recent KIDS News
Neutral News
Positive News
DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
11/8/2024Needham & Company LLC
3 of 5 stars
 Reiterated RatingBuy ➝ Buy$42.00 ➝ $42.00+52.78%
10/14/2024Truist Financial
2 of 5 stars
 Lower TargetHold ➝ Hold$34.00 ➝ $28.00+13.22%
9/13/2024JMP Securities
2 of 5 stars
 Reiterated RatingMarket Outperform ➝ Market Outperform$50.00 ➝ $50.00+51.93%
10/3/2023BTIG Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetBuy ➝ Buy$59.00 ➝ $52.00+65.03%
1/10/2023Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetBuy$52.00 ➝ $50.00+12.97%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Sunday at 06:22 PM ET.


KIDS Forecast - Frequently Asked Questions

According to the research reports of 3 Wall Street equities research analysts, the average twelve-month stock price forecast for OrthoPediatrics is $40.00, with a high forecast of $50.00 and a low forecast of $28.00.

3 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for OrthoPediatrics in the last year. There is currently 1 hold rating and 2 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "moderate buy" KIDS shares.

According to analysts, OrthoPediatrics's stock has a predicted upside of 51.86% based on their 12-month stock forecasts.

OrthoPediatrics has been rated by research analysts at JMP Securities, Needham & Company LLC, and Truist Financial in the past 90 days.

Analysts like OrthoPediatrics less than other "medical" companies. The consensus rating score for OrthoPediatrics is 2.67 while the average consensus rating score for "medical" companies is 2.80. Learn more on how KIDS compares to other companies.


This page (NASDAQ:KIDS) was last updated on 11/24/2024 by MarketBeat.com Staff
From Our Partners